Philip Palade
Professor
faculty
Pharmacology & Toxicology, College of Medicine
Research Areas
Biography and Research Information
OverviewAI-generated summary
Philip Palade, Professor in the Department of Pharmacology & Toxicology at the University of Arkansas for Medical Sciences, investigates molecular mechanisms underlying diseases, with a recent focus on cardiovascular diseases and neurodegenerative conditions. His work has explored the role of proteins such as RALBP1 in oxidative stress and mitochondrial dysfunction, particularly in the context of Alzheimer's disease and mammary carcinogenesis. He has also studied the impact of PCSK9 on smooth muscle cell senescence and apoptosis, and its broader implications in cardiovascular health beyond cholesterol metabolism. Further research interests include the immune pathways involved in hypertension and the anticancer activities of specific dietary components, such as omega-6 fatty acids and sulforaphane.
Dr. Palade's scholarship includes 128 publications and over 5,100 citations, reflected in an h-index of 39. He is recognized as a highly cited researcher. His collaborations within the University of Arkansas for Medical Sciences include significant work with Sharda P. Singh (6 shared publications), Chhanda Bose (5 shared publications), Yunmeng Liu (2 shared publications), and Katherine Deck (2 shared publications). Dr. Palade maintains an active research group and laboratory website, indicating ongoing research activities.
Metrics
- h-index: 39
- Publications: 128
- Citations: 5,110
Selected Publications
-
Uncovering immune pathways for therapeutic targeting of hypertension (2025)
-
Immune Dysregulation Connecting Type 2 Diabetes and Cardiovascular Complications (2025)
-
The pleiotropic effects of PCSK9 in cardiovascular diseases beyond cholesterol metabolism (2025)
-
Direct Impact of PCSK9 on SMC Senescence and Apoptosis: A New Focus in Cardiovascular Diseases (2024)
-
Book Review of Heart Disease: It is All in Your Head, and What to Do About It (2022)
-
Rlip Depletion Alters Oncogene Transcription at Multiple Distinct Regulatory Levels (2022)
-
Anticancer Activity of Ω-6 Fatty Acids through Increased 4-HNE in Breast Cancer Cells (2021)
-
RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease (2021)
-
Role of RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease (2021)
-
Dietary supplementation with sulforaphane ameliorates skin aging through activation of the Keap1-Nrf2 pathway (2021)
-
Haploinsufficiency Interactions between RALBP1 and p53 in ERBB2 and PyVT Models of Mouse Mammary Carcinogenesis (2021)
Grants & Funding
- CALCIUM RELEASE FROM ISOLATED SARCOPLASMIC RETICULUM NIH Principal Investigator
- Cav1.2 Transcript Regulation in Heart and Smooth Muscle NIH Principal Investigator
- RNA interference to decrease vascular CaV1.2 in hypertension American Heart Association (South Central Affiliate) Principal Investigator
- THE ALPHA-1C CALCIUM CHANNEL IN MUSCLE NIH Principal Investigator
- CA RELEASE FROM SARCOPLASMIC RETICULUM: THE FROG PACKAGE NIH Principal Investigator
- PHARMACOLOGY OF MUSCLE EXCITATION-CONTRACTION COUPLING NIH Principal Investigator
- CALCIUM RELEASE PROCESS OF SARCOPLASMIC RETICULUM NIH Principal Investigator
- CALCIUM RELEASE PROCESS OF SARCOPLASMIC RETICULUM NIH Principal Investigator
Collaboration Network
Top Collaborators
- Dietary supplementation with sulforaphane ameliorates skin aging through activation of the Keap1-Nrf2 pathway
- RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease
- Anticancer Activity of Ω-6 Fatty Acids through Increased 4-HNE in Breast Cancer Cells
- Haploinsufficiency Interactions between RALBP1 and p53 in ERBB2 and PyVT Models of Mouse Mammary Carcinogenesis
- Role of RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease
Showing 5 of 6 shared publications
- Dietary supplementation with sulforaphane ameliorates skin aging through activation of the Keap1-Nrf2 pathway
- RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease
- Anticancer Activity of Ω-6 Fatty Acids through Increased 4-HNE in Breast Cancer Cells
- Haploinsufficiency Interactions between RALBP1 and p53 in ERBB2 and PyVT Models of Mouse Mammary Carcinogenesis
- Role of RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease
Showing 5 of 6 shared publications
- RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease
- Anticancer Activity of Ω-6 Fatty Acids through Increased 4-HNE in Breast Cancer Cells
- Haploinsufficiency Interactions between RALBP1 and p53 in ERBB2 and PyVT Models of Mouse Mammary Carcinogenesis
- Role of RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease
- Rlip Depletion Alters Oncogene Transcription at Multiple Distinct Regulatory Levels
- RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease
- Anticancer Activity of Ω-6 Fatty Acids through Increased 4-HNE in Breast Cancer Cells
- Haploinsufficiency Interactions between RALBP1 and p53 in ERBB2 and PyVT Models of Mouse Mammary Carcinogenesis
- Rlip Depletion Alters Oncogene Transcription at Multiple Distinct Regulatory Levels
- Anticancer Activity of Ω-6 Fatty Acids through Increased 4-HNE in Breast Cancer Cells
- Haploinsufficiency Interactions between RALBP1 and p53 in ERBB2 and PyVT Models of Mouse Mammary Carcinogenesis
- Rlip Depletion Alters Oncogene Transcription at Multiple Distinct Regulatory Levels
- RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease
- Role of RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease
- Rlip Depletion Alters Oncogene Transcription at Multiple Distinct Regulatory Levels
- Anticancer Activity of Ω-6 Fatty Acids through Increased 4-HNE in Breast Cancer Cells
- Haploinsufficiency Interactions between RALBP1 and p53 in ERBB2 and PyVT Models of Mouse Mammary Carcinogenesis
- Anticancer Activity of Ω-6 Fatty Acids through Increased 4-HNE in Breast Cancer Cells
- Haploinsufficiency Interactions between RALBP1 and p53 in ERBB2 and PyVT Models of Mouse Mammary Carcinogenesis
- RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease
- Role of RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease
- RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease
- Role of RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease
- RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease
- Role of RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease
- RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease
- Role of RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease
- RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease
- Role of RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease
- RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease
- Role of RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease
- RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease
- Role of RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease
Similar Researchers
Based on overlapping research topics